Moreover, using liraglutide alone vs
"Both semaglutide and tirzepatide are well-known for their effects on weight loss and blood sugar control, but our study suggests they may also offer substantial benefits to patients with obesity and type 2 diabetes by reducing adverse heart failure outcomes." Despite promising results from existing randomized controlled trials of semaglutide and tirzepatide in those with obesity-related HFpEF, regulatory authorities and professional societies have not approved or endorsed the use of these drugs for HFpEF, due in part to the studies relatively small sample sizes and unknown generalizability
Like insulin and other injectable medications, semaglutide is a biological medication that is sensitive to time and temperature
This physiological change makes many patients naturally eat less without conscious restriction, reducing overall calorie intake across the week
The oral Wegovy tablet approved for chronic weight management is also outside this article's scope and is distinct from Rybelsus, which is labeled for type 2 diabetes
Please like, share and subscribe
